Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Leht 1 alates 20 tulemused
Use of serotonin agents for adjunct therapy in the treatment of cancer
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention relates to the use of serotonin agents in the treatment of malignancies. More specifically, this invention relates to the use of agents that affect serotonin neurotransmission, e.g., serotonergic agents, serotonin reuptake inhibitors and selective serotonin
Methods of treating and preventing leukemia and other cancers of the blood and bone
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention is in the field of preventing and treating leukemia and other cancers, especially those of the blood and bone, as well as other disorders of the blood, by increasing osteoblast proliferation, preferably by inhibiting serotonin.
BACKGROUND OF THE
Method for treatment of cancer and infectious disease
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention concerns a pharmaceutical preparation or system for activation of natural killer cells (NK-cells), in order, for example, to treat tumors or virus infections.
SUMMARY OF THE INVENTION
Natural killer cells (NK-cells) are a group of spontaneously cytotoxic
Method for treatment of cancer and infectious disease
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention concerns a pharmaceutical preparation or system for activation of natural killer cells (NK-cells), in order, for example, to treat tumors or virus infections.
SUMMARY OF THE INVENTION
Natural killer cells (NK-cells) are a group of spontaneously cytotoxic
Method of medical treatment with serotonin antagonists
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF INVENTION
(a) Field of the Invention
This invention relates to a method of treatment of conditions such as bladder carcinoma, lung carcinoma, breast carcinoma, carcinoma of adrenal cortex, or pancreatic carcinoma by serotonin antagonists and primarily cyproheptadine.
(b) Description of
Preparation for activation of natural killer cells (NK-cells), said preparation containing interferon-alpha and histamine, serotonin, amines or substances with corresponding receptor activity
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention concerns a pharmaceutical preparation or system for activation of natural killer cells (NK-cells), in order for example, to treat tumors or virus infections.
BACKGROUND OF THE INVENTION
Natural killer cells (NK-cells) are a group of spontaneously
N-cyano-N'-pyridylguanidines as serotonin antagonists
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The present invention relates to a series of compounds, their pharmaceutically acceptable salts, and their N-oxides, to methods for preparing the said compounds, salts or N-oxides, to pharmaceutical compositions containing said compounds, to dosage units of the compositions, and to methods of
Spirocyclic compounds as tryptophan hydroxylase inhibitors
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example,
Spirocyclic compounds as tryptophan hydroxylase inhibitors
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example,
Spirocyclic compounds as tryptophan hydroxylase inhibitors
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example,
Spirocyclic compounds as tryptophan hydroxylase inhibitors
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example,
Spirocyclic compounds as tryptophan hydroxylase inhibitors
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example,
Pyrazinooxazepine derivatives
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This application is a U.S. national stage of International Application No. PCT/JP2010/060408 filed Jun. 14, 2010.
TECHNICAL FIELD OF THE INVENTION
The present invention relates to a pyrazinooxazepine derivative having a superior serotonin 5-HT.sub.2C receptor activating action and useful as an agent
Processes for preparing (R)-1-(5-chloro-[1,1'-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1'-biphenyl]-2-yl)-2,2,2-trifluoroethanone
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention relates to processes for the preparation of (R)-1-(5-chloro-[1,1'-biphenyl]-2-yl)-2,2,2-trifluoroethanol, 1-(5-chloro-[1,1'-biphenyl]-2-yl)-2,2,2-trifluoroethanone, and intermediates thereof, which are useful in the synthesis of inhibitors of TPH1 for the
Processes for preparing (R)-1-(5-chloro-[1,1''-biphenyl] -2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1''-biphenyl]-2-yl)-2,2,2-trifluoroethanone
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention relates to processes for the preparation of (R)-1-(5-chloro-[1,1'-biphenyl]-2-yl)-2,2,2-trifluoroethanol, 1-(5-chloro-[1,1'-biphenyl]-2-yl)-2,2,2-trifluoroethanone, and intermediates thereof, which are useful in the synthesis of inhibitors of TPH1 for the
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
